Cargando…
Evaluating [(18)F]FDG and [(18)F]FLT Radiotracers as Biomarkers of Response for Combined Therapy Outcome in Triple-Negative and Estrogen-Receptor-Positive Breast Cancer Models
Breast cancer (BC) is the most frequent cancer and the second leading cause of death in women. A typical feature of BC cells is the metabolic shift toward increased glycolysis, which has become an interesting therapeutic target for metabolic drugs such as metformin (MET). Recently, the administratio...
Autores principales: | Rainone, Paolo, Valtorta, Silvia, Villa, Chiara, Todde, Sergio, Cadamuro, Massimiliano, Bertoli, Gloria, Conconi, Donatella, Lavitrano, Marialuisa, Moresco, Rosa Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532149/ https://www.ncbi.nlm.nih.gov/pubmed/37762429 http://dx.doi.org/10.3390/ijms241814124 |
Ejemplares similares
-
[(18)F]FDG and [(18)F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer
por: Raccagni, Isabella, et al.
Publicado: (2018) -
Study of the Tissue Distribution of TLQP-21 in Mice Using [(18)F]JMV5763, a Radiolabeled Analog Prepared via [(18)F]Aluminum Fluoride Chelation Chemistry
por: Turolla, Elia A., et al.
Publicado: (2018) -
PET Cell Tracking Using (18)F-FLT is Not Limited by Local Reuptake of Free Radiotracer
por: MacAskill, Mark G., et al.
Publicado: (2017) -
Novel Radiotracers for Molecular Imaging of Myocardial Inflammation: an Update Focused on Clinical Translation of Non-18F-FDG Radiotracers
por: Shi, Tiantian, et al.
Publicado: (2023) -
Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)